Lv2
130 积分 2022-06-24 加入
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
1天前
待确认
Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity
1天前
已完结
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
4天前
已完结
Enhancing CAR T-cell therapy through cellular imaging and radiotherapy
3个月前
已完结
TREM1/DAP12 based novel multiple chain CAR‐T cells targeting DLL3 show robust anti‐tumour efficacy for small cell lung cancer
3个月前
已完结
Integration of ζ-deficient CARs into theCD3-zetagene conveys potent cytotoxicity in T and NK cells
4个月前
已完结
Final Results of a Phase 1 Study of AntiCD19 CAR-T Cells with TNFRSF19 Transmembrane Domain
4个月前
已关闭
Current understanding and management of CAR T cell-associated toxicities
4个月前
已完结
A co-stimulatory domain increases CAR T cell therapy efficacy in mice with solid tumors
4个月前
已完结
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors
5个月前
已完结
皖公网安备34019202002308
